Menu

Imperial Innovations portfolio of companies

Imperial Innovations has a portfolio made up of 93 companies (as at 31 January 2014) covering a range of sectors, but primarily in the areas of therapeutics, medtech, engineering and ICT. Innovations manages its portfolio of companies actively, taking a seat on the board of companies it invests in and providing guidance on management recruitment, intellectual property strategy and overall company development.

The top thirty companies in Imperial Innovations portfolio by value represent 98.5% of the total value of the portfolio, and the top 20 companies set out in the table below represent 94.7% of the Group's portfolio value. This top group of companies, in addition to newly founded and seed-funded companies, is the primary focus of our active portfolio management.

Top 20 companies by value


Company

Net Investment Carrying Value* (£ '000)

% issued share capital held*

Circassia 73,920 14.0%**
Nexeon 34,086 38.0%
Veryan Medical 16,967 44.3%
Abzena 11,153 25.2%
Oxford Immunotec 10,686 4.8%
Cell Medica 7,979 30.0%
PsiOxus Therapeutics 7,892 29.9%
Plaxica 6,446 44.0%
Stanmore Implants 6,268 16.0%
Econic Technologies 6,145 53.6%
Autifony 6,060 31.0%
TopiVert 5,955 33.4%
Cortexica 3,929 30.0%
EVO Electric 3,786 34.1%
Crescendo Biologics 3,250 18.4%
Mission Therapeutics 2,974 20.0%
Nascient 2,750 78.8%
Abingdon Health 3,685 36.4%
Process Systems Enterprise 1,817 23.3%
Pulmocide 1,750 17.6%

*All figures are correct as of January 31st 2014
** Circassia shareholding calcuated post 18th March IPO